- Home
- COYA vs NMT Comparison
COYA vs NMT Comparison
Compare COYA & NMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- NMT
- Stock Information
- Founded
- COYA 2020
- NMT 1993
- Country
- COYA United States
- NMT United States
- Employees
- COYA N/A
- NMT N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- NMT Finance/Investors Services
- Sector
- COYA Health Care
- NMT Finance
- Exchange
- COYA Nasdaq
- NMT Nasdaq
- Market Cap
- COYA 107.0M
- NMT 107.8M
- IPO Year
- COYA 2022
- NMT N/A
- Fundamental
- Price
- COYA $6.29
- NMT $11.60
- Analyst Decision
- COYA Strong Buy
- NMT
- Analyst Count
- COYA 5
- NMT 0
- Target Price
- COYA $16.20
- NMT N/A
- AVG Volume (30 Days)
- COYA 289.4K
- NMT 19.1K
- Earning Date
- COYA 11-06-2025
- NMT 01-01-0001
- Dividend Yield
- COYA N/A
- NMT 3.21%
- EPS Growth
- COYA N/A
- NMT N/A
- EPS
- COYA N/A
- NMT N/A
- Revenue
- COYA $423,452.00
- NMT N/A
- Revenue This Year
- COYA $40.80
- NMT N/A
- Revenue Next Year
- COYA N/A
- NMT N/A
- P/E Ratio
- COYA N/A
- NMT N/A
- Revenue Growth
- COYA N/A
- NMT N/A
- 52 Week Low
- COYA $4.65
- NMT $9.05
- 52 Week High
- COYA $9.64
- NMT $10.93
- Technical
- Relative Strength Index (RSI)
- COYA 49.12
- NMT 46.50
- Support Level
- COYA $6.07
- NMT $11.50
- Resistance Level
- COYA $6.77
- NMT $11.60
- Average True Range (ATR)
- COYA 0.62
- NMT 0.07
- MACD
- COYA -0.02
- NMT -0.00
- Stochastic Oscillator
- COYA 23.96
- NMT 38.46
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.